 
										

21 Jun 2025
// PRESS RELEASE

11 Dec 2023
// Angus Liu FIERCE PHARMA
https://www.fiercepharma.com/pharma/roche-offers-glimpse-columvi-polivy-combos-early-data-untreated-dlbcl-ph3-kicks

24 Aug 2023
// Lei Lei Wu ENDPTS
https://endpts.com/after-first-line-approval-in-dlbcl-debate-continues-around-benefit-from-roches-adc-polivy/

14 Jul 2023
// Ben Adams FIERCE PHARMA
https://www.fiercepharma.com/marketing/roche-mirroring-novartis-guilty-most-serious-marketing-breach-polivy-website

20 Apr 2023
// Angus Liu FIERCE PHARMA
https://www.fiercepharma.com/pharma/roche-wins-hard-fought-fda-approval-polivy-changing-20-years-lymphoma-practice

10 Mar 2023
// Paul Schloesser ENDPTS
https://endpts.com/fda-adcomm-votes-11-2-to-expand-roches-polivy-label-in-dlbcl/